ENTITY
Sinopharm Group

Sinopharm Group (1099 HK)

171
Analysis
Health Care • China
Sinopharm Group is a leading Chinese distributor and retailer of pharmaceutical and healthcare products, medical devices, and a supply chain service provider. The company also engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. It was incorporated in January 2003 and is headquartered in Shanghai, China.
more
bullish•Keppel
•21 Jun 2020 07:58

Last Week in Event SPACE: Wirecard, Skyworth, Nichii Gakkan, Yixin, Perennial, 58.Com, Keppel

Last Week in EventĀ SPACEĀ ... Wirecard AG (WDI GR) is too toxic to touch, even from the long side with a barge pole, until all this fraud is...

Logo
643 Views
Share
bullish•Alibaba
•18 Jun 2020 14:56

HSCEI Index Rebalance Preview - September 2020

The Hang Seng Indexes Company Limited (HSIL) will announce the results of the 2020 Q2 review of the Hang Seng Family of Indexes in mid August. The...

Logo
854 Views
Share
•13 May 2020 07:56

China Health Care - Allocation Boom: Wuxi Biologics/Jinyu Bio-Tech/Hangzhou Tigermed Top Picks

With increased focus on the Health Care sector in light of the COVID-19 pandemic, Health Care allocations reached record levels last month. We...

Logo
492 Views
Share
•19 Jan 2020 11:38

ECM Weekly (19 Jan 2020) - Mr. DIY, UTI AMC, Sinopharm, Sunac, Jinxin, China Lit

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. This week...

Share
bearish•Sinopharm Group
•16 Jan 2020 22:48

Sinopharm (å›½åŒ»ęŽ§č‚”) Placement - Unattractive but Inexpensive

Sinopharm Group Co H (1099 HK) is looking to raise about US$539m in its placement.Ā Overall, the deal scores negatively on our framework owing to...

Share
x